Table 1.
Characteristics | HR+/HER2+ (n = 20) |
HR+/HER2− (n = 20) |
HR−/HER2+ (n = 21) |
HR−/HER2− (TNBC) (n = 20) |
P |
---|---|---|---|---|---|
Age (mean ± SD) | 55.75 ± 13.32 | 56.45 ± 14.24 | 58.24 ± 11.48 | 55.90 ± 11.63 | 0.9183 1 |
Max. tumor dimension (mean ± SD) | 2.26 ± 1.18 | 4.36 ± 3.29 | 2.51 ± 1.52 | 2.47 ± 0.96 | 0.0019 1 |
Histological grade 2 | 0.0002 3 | ||||
I | 0 | 4 | 0 | 1 | |
II | 15 | 8 | 6 | 3 | |
III | 5 | 7 | 15 | 15 | |
Tumor stage 2 | 0.0009 3 | ||||
T1 | 12 | 1 | 9 | 8 | |
T2 | 6 | 15 | 11 | 11 | |
T3 | 0 | 4 | 0 | 0 | |
T4 | 2 | 0 | 1 | 0 | |
Nodal stage 2 | 0.1181 3 | ||||
N0 | 12 | 8 | 10 | 12 | |
N1 | 4 | 4 | 6 | 4 | |
N2 | 3 | 4 | 4 | 2 | |
N3 | 0 | 4 | 0 | 0 | |
Clinical stage 2 | 0.0316 3 | ||||
I | 7 | 0 | 7 | 4 | |
II | 8 | 11 | 9 | 13 | |
III | 4 | 9 | 5 | 2 | |
Ever smoked 2 | 0.0588 3 | ||||
Yes | 1 | 7 | 4 | 7 | |
No | 8 | 12 | 9 | 3 | |
Menopausal status 2 | 0.5140 3 | ||||
Pre-menopause | 7 | 4 | 4 | 4 | |
Post-menopause | 10 | 11 | 17 | 10 |
1 ANOVA; 2 Data not available for all samples; 3 Chi-square test using available data.